HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alessandro Ceschi Selected Research

Alessandro Ceschi Research Topics

Disease

10Poisoning
01/2022 - 03/2010
7Seizures (Absence Seizure)
02/2021 - 03/2010
5COVID-19
01/2022 - 11/2020
3Drug-Related Side Effects and Adverse Reactions
03/2021 - 04/2015
2Infections
06/2022 - 01/2021
2Disease Progression
05/2022 - 05/2011
2Zoonoses
01/2022 - 12/2021
2Hallucinations (Hallucination)
01/2022 - 01/2020
2Myocarditis (Carditis)
11/2020 - 01/2018
2Chest Pain (Chest Pains)
01/2020 - 01/2014
2Respiratory Insufficiency (Respiratory Failure)
01/2020 - 10/2013
2Fever (Fevers)
01/2015 - 01/2014
2Confusion (Bewilderment)
12/2014 - 07/2012
2Hypertension (High Blood Pressure)
12/2014 - 07/2012
2Tachycardia (Tachyarrhythmias)
12/2014 - 07/2012
1Breakthrough Infections
06/2022
1Facial Paralysis (Facial Palsy)
09/2021
1Bell Palsy (Bell's Palsy)
09/2021
1Brachial Plexus Neuritis (Parsonage Turner Syndrome)
09/2021
1Guillain-Barre Syndrome
09/2021
1Premature Birth (Birth, Premature)
01/2021
1Spontaneous Abortion (Miscarriage)
01/2021
1Congenital Abnormalities (Deformity)
01/2021
1Intussusception
12/2020
1Type 2 Diabetes Mellitus (MODY)
12/2020
1Fibrosis (Cirrhosis)
11/2020
1Hepatocellular Carcinoma (Hepatoma)
11/2020
1Coma (Comas)
01/2020
1Neoplasms (Cancer)
01/2020
1Panic Disorder (Panic Attack)
01/2020
1Psychotic Disorders (Schizoaffective Disorder)
01/2020
1Cytokine Release Syndrome
01/2020
1Low Cardiac Output
01/2019
1Rhabdomyolysis
01/2019
1Chronic Disease (Chronic Diseases)
12/2018
1Drug Hypersensitivity Syndrome
01/2018
1Substance-Related Disorders (Drug Abuse)
11/2016
1Alcoholism (Alcohol Abuse)
11/2016
1Depressive Disorder (Melancholia)
04/2016
1Gastroenteritis
01/2015
1Amnesia (Dissociative Amnesia)
12/2014
1Echolalia
12/2014
1Epilepsy (Aura)
01/2014
1Dyspnea (Shortness of Breath)
01/2014
1Cough
01/2014
1Superinfection
01/2014
1Agranulocytosis (Granulocytopenia)
01/2014

Drug/Important Bio-Agent (IBA)

5VaccinesIBA
06/2022 - 11/2020
5PoisonsIBA
01/2022 - 06/2012
5Pharmaceutical PreparationsIBA
01/2021 - 10/2010
3AntibodiesIBA
06/2022 - 02/2021
3Monoclonal AntibodiesIBA
01/2022 - 01/2021
3Immune Checkpoint InhibitorsIBA
11/2020 - 01/2018
2EpitopesIBA
01/2022 - 12/2021
2Antidepressive Agents (Antidepressants)IBA
04/2016 - 03/2010
2Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
04/2016 - 03/2010
2Antipsychotic Agents (Antipsychotics)IBA
06/2014 - 09/2010
1N-(2-cyanoethylene)urea (BA 1)IBA
06/2022
1N-methyl-valyl-amiclenomycin (BA 2)IBA
06/2022
1Messenger RNA (mRNA)IBA
05/2022
1EchinocandinsIBA
01/2022
1TriazolesIBA
01/2022
1AzolesIBA
01/2022
1Flucytosine (Ancobon)FDA Link
01/2022
1COVID-19 VaccinesIBA
09/2021
1Glycoproteins (Glycoprotein)IBA
09/2021
1Antineoplastic Agents (Antineoplastics)IBA
03/2021
1WastewaterIBA
02/2021
1N-Methyl-3,4-methylenedioxyamphetamine (MDMA)IBA
02/2021
1Angiotensin-Converting Enzyme 2IBA
01/2021
1Protective AgentsIBA
01/2021
1Tryptamines (Triptans)IBA
01/2021
1Proteins (Proteins, Gene)FDA Link
01/2021
1erenumabIBA
01/2021
1galcanezumabIBA
01/2021
1fremanezumabIBA
01/2021
1Viral RNAIBA
12/2020
1Neutralizing AntibodiesIBA
11/2020
1Rosuvastatin Calcium (Crestor)FDA Link
01/2019
1beta-thujone (thujone)IBA
08/2018
1C-Reactive ProteinIBA
01/2018
1ProcalcitoninIBA
01/2018
1Biomarkers (Surrogate Marker)IBA
01/2018
1Cephalosporins (Cephalosporin Antibiotics)IBA
11/2016
1ORALIT (ORS)IBA
11/2016
1Serotonin and Noradrenaline Reuptake InhibitorsIBA
04/2016
1Norepinephrine (Noradrenaline)FDA LinkGeneric
04/2016
1Serotonin (5 Hydroxytryptamine)IBA
04/2016
1Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA
04/2016
1TolperisoneIBA
06/2015
1Sirolimus (Rapamycin)FDA Link
01/2015
1CholesterolIBA
01/2015
1Alkaline PhosphataseIBA
01/2015
1Phencyclidine (Angel Dust)IBA
12/2014
1Petroleum (Crude Oil)IBA
01/2014
1Azathioprine (Imuran)FDA LinkGeneric
01/2014
1Anti-Bacterial Agents (Antibiotics)IBA
01/2014
1Allopurinol (Remid)FDA LinkGeneric
01/2014

Therapy/Procedure

1Liver Transplantation
11/2020
1Critical Care (Surgical Intensive Care)
01/2020